Skip to main content
OpenTrials

Clinical trial condition

Diabetes Mellitus, Type 2

Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.

8,001 public trials 713 recruiting studies
Refine in advanced search Browse all conditions

Diabetes Mellitus, Type 2 trial results

Completed

Effect of Two Different Fasting Blood Glucose Targets on Glucose Control in Patients With Type 2 Diabetes Using Insulin Detemir Once Daily

NCT00634842

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Goodyear, Arizona, United States
  • Novo Nordisk Investigational Site Scottsdale, Arizona, United States
  • Novo Nordisk Investigational Site Searcy, Arkansas, United States
  • Novo Nordisk Investigational Site Artesia, California, United States
View all 69 locations
View Trial Details
Completed

Comparison of Insulin Detemir, Insulin Aspart and Biphasic Insulin Aspart 30 With OAD Treatment in Type 2 Diabetes

NCT00184600

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Dublin, Ireland
  • Novo Nordisk Investigational Site Dublin, Ireland
  • Novo Nordisk Investigational Site Dublin, Ireland
  • Novo Nordisk Investigational Site Galway, Ireland
View all 63 locations
View Trial Details
Completed

Evaluation of CONTOUR® USB BGMS on Glycaemic Control in Insulin-treated Diabetic Patients

NCT01588106

Conditions
Diabetes Mellitus, Diabetes Mellitus Type 2, Diabetes Mellitus, Type 2, +4 more
Locations
  • Diabetespraxis Prenzlauer Allee Berlin, Germany
  • Praxis Dr. Fießelmann Berlin, Germany
  • Praxis Dr. Stephan Berlin, Germany
  • Gemeinschaftspraxis Lorra/Bonnermann Bochum, Germany
View all 16 locations
View Trial Details
Completed

The Efficacy and Safety of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin in Chinese Subjects With Type 2 Diabetes

NCT02008682

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Beijing, Beijing Municipality, China
  • Novo Nordisk Investigational Site Beijing, Beijing Municipality, China
  • Novo Nordisk Investigational Site Beijing, Beijing Municipality, China
  • Novo Nordisk Investigational Site Chongqing, Chongqing Municipality, China
View all 25 locations
View Trial Details
Completed

Effect of Liraglutide or Exenatide Added to an Ongoing Treatment on Blood Glucose Control in Subjects With Type 2 Diabetes

NCT00518882

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Birmingham, Alabama, United States
  • Novo Nordisk Investigational Site Goodyear, Arizona, United States
  • Novo Nordisk Investigational Site Artesia, California, United States
  • Novo Nordisk Investigational Site Encino, California, United States
View all 125 locations
View Trial Details

Related conditions